UBS Group AG Lowers Position in Chimera Investment Corporation (CIM)

UBS Group AG decreased its position in Chimera Investment Corporation (NYSE:CIM) by 11.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,539,193 shares of the real estate investment trust’s stock after selling 193,074 shares during the period. UBS Group AG owned approximately 0.82% of Chimera Investment Corporation worth $31,061,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of CIM. Credit Agricole S A bought a new stake in shares of Chimera Investment Corporation during the fourth quarter worth $110,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Chimera Investment Corporation by 80.9% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,869 shares of the real estate investment trust’s stock worth $159,000 after buying an additional 3,519 shares during the period. Sit Investment Associates Inc. boosted its stake in shares of Chimera Investment Corporation by 143.6% in the first quarter. Sit Investment Associates Inc. now owns 9,500 shares of the real estate investment trust’s stock worth $192,000 after buying an additional 5,600 shares during the period. Snow Capital Management LP bought a new stake in shares of Chimera Investment Corporation during the first quarter worth $201,000. Finally, Loomis Sayles & Co. L P bought a new stake in shares of Chimera Investment Corporation during the fourth quarter worth $201,000. Hedge funds and other institutional investors own 55.68% of the company’s stock.

Institutional Ownership by Quarter for Chimera Investment Corporation (NYSE:CIM)

Shares of Chimera Investment Corporation (NYSE:CIM) traded up 0.82% on Monday, hitting $19.58. The stock had a trading volume of 1,155,581 shares. The stock has a 50 day moving average price of $18.69 and a 200-day moving average price of $18.62. Chimera Investment Corporation has a 12-month low of $14.70 and a 12-month high of $20.90. The company has a market cap of $3.68 billion, a price-to-earnings ratio of 5.90 and a beta of 0.83.

Chimera Investment Corporation (NYSE:CIM) last posted its earnings results on Monday, May 1st. The real estate investment trust reported $0.51 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.07. Chimera Investment Corporation had a net margin of 64.18% and a return on equity of 14.14%. The firm had revenue of $141.11 million during the quarter, compared to analysts’ expectations of $140.90 million. During the same period in the previous year, the firm posted $0.58 earnings per share. The firm’s revenue for the quarter was up 2.1% on a year-over-year basis. On average, equities analysts expect that Chimera Investment Corporation will post $2.37 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 30th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 10.21%. The ex-dividend date is Wednesday, June 28th. Chimera Investment Corporation’s payout ratio is currently 60.24%.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by BBNS and is owned by of BBNS. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://baseballnewssource.com/markets/chimera-investment-corporation-cim-position-cut-by-ubs-group-ag-updated/985352.html.

A number of brokerages recently weighed in on CIM. ValuEngine upgraded Chimera Investment Corporation from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 3rd. BidaskClub upgraded Chimera Investment Corporation from a “hold” rating to a “buy” rating in a research note on Thursday. Barclays PLC set a $17.00 price target on Chimera Investment Corporation and gave the company a “hold” rating in a research note on Monday, May 8th. Finally, Zacks Investment Research cut Chimera Investment Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, April 19th. Six analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $17.75.

About Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust (REIT). The company is engaged in the business of investing in a portfolio of mortgage assets, including agency residential mortgage-backed security (RMBS), non-agency RMBS, agency commercial mortgage-backed securities (CMBS), residential mortgage loans and real estate related securities.

Receive News & Ratings for Chimera Investment Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment Corporation and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.